Barry D Quart - Net Worth and Insider Trading
Barry D Quart Net Worth
The estimated net worth of Barry D Quart is at least $189,777 dollars as of 2024-09-20. Barry D Quart is the CEO of Heron Therapeutics Inc and owns about 94,652 shares of Heron Therapeutics Inc (HRTX) stock worth over $189,777. Barry D Quart is also the Director of Kiniksa Pharmaceuticals International PLC and owns about 0 shares of Kiniksa Pharmaceuticals International PLC (KNSA) stock worth over $0. Details can be seen in Barry D Quart's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Barry D Quart has not made any transactions after 2022-11-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Barry D Quart
Barry D Quart Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Barry D Quart owns 2 companies in total, including Heron Therapeutics Inc (HRTX) , and Kiniksa Pharmaceuticals International PLC (KNSA) .
Click here to see the complete history of Barry D Quart’s form 4 insider trades.
Insider Ownership Summary of Barry D Quart
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HRTX | Heron Therapeutics Inc | 2019-10-03 | director & Chief Executive Officer |
| KNSA | Kiniksa Pharmaceuticals International PLC | 2022-11-29 | director |
Barry D Quart Latest Holdings Summary
Barry D Quart currently owns a total of 2 stocks. Among these stocks, Barry D Quart owns 94,652 shares of Heron Therapeutics Inc (HRTX) as of October 3, 2019, with a value of $189,777 and a weighting of 100%. Barry D Quart also owns 0 shares of Kiniksa Pharmaceuticals International PLC (KNSA) as of November 29, 2022, with a value of $0 and a weighting of 0%.
Latest Holdings of Barry D Quart
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HRTX | Heron Therapeutics Inc | 2019-10-03 | 94,652 | 2.01 | 189,777 |
| KNSA | Kiniksa Pharmaceuticals International PLC | 2022-11-29 | 0 | 26.27 | 0 |
Holding Weightings of Barry D Quart
Barry D Quart Form 4 Trading Tracker
According to the SEC Form 4 filings, Barry D Quart has made a total of 1 transactions in Heron Therapeutics Inc (HRTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Heron Therapeutics Inc is the acquisition of 4,571 shares on October 3, 2019, which cost Barry D Quart around $79,993.
According to the SEC Form 4 filings, Barry D Quart has made a total of 1 transactions in Kiniksa Pharmaceuticals International PLC (KNSA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Kiniksa Pharmaceuticals International PLC is the sale of 21,959 shares on November 29, 2022, which brought Barry D Quart around $354,638.
Insider Trading History of Barry D Quart
- 1
Barry D Quart Trading Performance
GuruFocus tracks the stock performance after each of Barry D Quart's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Barry D Quart is 18.22%. GuruFocus also compares Barry D Quart's trading performance to market benchmark return within the same time period. The performance of stocks bought by Barry D Quart within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Barry D Quart's insider trading performs compared to the benchmark.
Performance of Barry D Quart
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.46 | | | | | |
| Relative Return to S&P 500(%) | 6.09 | | | | | |
Barry D Quart Ownership Network
Barry D Quart Owned Company Details
What does Heron Therapeutics Inc do?
Who are the key executives at Heron Therapeutics Inc?
Barry D Quart is the director & Chief Executive Officer of Heron Therapeutics Inc. Other key executives at Heron Therapeutics Inc include EVP & Chief Development Officer William P Forbes , other: See Footnote 2 Adam Morgan , and EVP & Chief Financial Officer Ira Duarte .
Heron Therapeutics Inc (HRTX) Insider Trades Summary
Over the past 18 months, Barry D Quart made no insider transaction in Heron Therapeutics Inc (HRTX). Other recent insider transactions involving Heron Therapeutics Inc (HRTX) include a net purchase of 2,486,744 shares made by Adam Morgan , and a net purchase of 50,000 shares made by William P Forbes .
In summary, during the past 3 months, insiders sold 0 shares of Heron Therapeutics Inc (HRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Heron Therapeutics Inc (HRTX) were sold and 2,536,744 shares were bought by its insiders, resulting in a net purchase of 2,536,744 shares.
Heron Therapeutics Inc (HRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Heron Therapeutics Inc Insider Transactions
Barry D Quart Mailing Address
Above is the net worth, insider trading, and ownership report for Barry D Quart. You might contact Barry D Quart via mailing address: C/o Intrabiotics Pharmaceuticals Inc, 1009 Oak Hill Road, Suite 201, Lafayette Ca 94549.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
